Working at Kymera
Our shared values and a deep commitment to improving patients’ lives are the guiding principles that drive our work and connect our diverse and experienced teams to Kymera’s mission. We strive to create an environment that empowers and inspires Kymerians, enabling our employees to learn and grow while working to improve the lives of patients.
Our Values Drive Our Culture
We are courageous, resilient, and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
Kymera is a pioneer and innovator in the TPD field – throughout the drug discovery process, all our projects share a strong and clear focus on inventing better therapeutics using our unique approach and ultimately addressing unmet needs for patients. We appreciate and celebrate innovation and data-driven decisions here, regardless of how big or how small they are.
We value trust and transparency from everyone. Our goals are shared, our decisions data-driven, and our camaraderie genuine.
I joined Kymera because I was interested in being a part of an innovative team that fearlessly treads forward in the degrader therapy space to develop medicines that will directly impact patient’s lives.
We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
One of the best things about Kymera is the people! Everyone is thoughtful, dedicated, and fun – and that’s not easy to come by. I genuinely enjoy connecting with team members, from collaborating on projects, solving problems, or catching up at a company social hour. People are at the heart of everything we do, enabling us to realize our mission of delivering exciting new medicines to patients.
Just like chimeric molecules combine two or more components to create a powerful and innovative therapeutic opportunity, together, we are greater than the sum of our parts.
We welcome like-minded pioneers to join us on our extraordinary journey as we create a culture where diverse perspectives are invited, transparency is the standard and collaboration is celebrated—all in service of our goal to revolutionize medicine. Kymera’s culture reflects our aspirational vision, and every person contributes to building the company we want to be—an organization where our sense of urgency and high standards reflect our commitment to changing the lives of patients.
Just like chimeric molecules combine two or more components to create a powerful and innovative therapeutic opportunity, together, we are greater than the sum of our parts.
We welcome like-minded pioneers to join us on our extraordinary journey as we create a culture where diverse perspectives are invited, transparency is the standard and collaboration is celebrated—all in service of our goal to revolutionize medicine. Kymera’s culture reflects our aspirational vision, and every person contributes to building the company we want to be—an organization where our sense of urgency and high standards reflect our commitment to changing the lives of patients.
Our medicinal chemists play a crucial role in our discovery programs by rationally designing protein degraders to achieve the desired biological effects. Heterobifunctional Degraders and Molecular Glues are complex molecules to effectively design and our chemists’ expertise is actively shaping the future of drug discovery and contributing to Kymera’s leadership in TPD.
What I enjoy most about working at Kymera is the opportunity to collaborate with highly experienced, talented, and dedicated scientists. Being part of a team where everyone is committed to excellence motivates me to contribute my best. Every day presents a chance to learn something new, and I find immense satisfaction in applying my skills and expertise to solve challenging problems. This continuous learning and the collective spirit of problem-solving make my work at Kymera truly enjoyable.
Our proteomics team brings together Mass Spectrometry-based proteomics with proteome editing through Kymera’s TPD platform, and is foundational to our drug discovery efforts. Proteomics works with most functions in drug discovery and has collaborated on company achievements such as the creation of the first-ever map of E3 ligases expression, which is enabling disease selective pharmacology, and has helped characterize several degraders on their journey to the clinic.
I was attracted to Kymera for its bold leadership, great culture, and long-term vision that fostered pioneering innovation I didn’t see elsewhere. I have stayed here for the opportunity, culture and collaboration that are in alignment with my purpose of making an impact in patient’s lives. I have been able to apply my knowledge and together we have pushed boundaries towards developing a technology platform that is set to yield transformative medicines for patients in need.
Our Clinical Development group has played a major role transforming the company from a research organization into one with multiple programs in the clinic. With a newer modality, the bar is high, and Kymera’s team has created and executed clinical strategies that have brought our programs to patients and built critical relationships with investigators and key opinion leaders.
My goal joining Kymera was to build a Clinical Development team that would transition our promising preclinical science into the clinic and a step closer to having meaningful impact for patients. What has kept me here are the people and the opportunities to constantly learn something new. I enjoy the genuine camaraderie that results from our shared vision.
Kymera’s Analytical Development team develops and implements analytical testing methods and control strategies to ensure that we produce drugs of high quality. Targeted Protein Degraders are challenging due to their unique chemical and physical properties, and working with them requires strong scientific skills, creativity, and collaboration. Our experienced analytical team plays an essential role in the development and eventual commercialization of our drug candidates.
I enjoy solving challenging technical issues, working in teams efficiently to speed up drug development, and help bring innovative medicines to patients. I find motivation in Kymera’s collaborative culture to drive innovation in Targeted Protein Degradation.
Get More Out of Life
We strive to give our people and their families benefit offerings that go above and beyond to support your emotional and financial wellbeing. We offer competitive programs that enable employees to better integrate work, family, and community in a healthy, meaningful way and make it easy for you to enjoy your journey at Kymera. These programs will ensure you are supported, create opportunities for growth, and better connect you to our Kymera community.
Need a break? We’ve got you covered. With three office shutdowns, summer hours, and paid time off, we want to give you the flexibility and time you need to step away from your work when you need it most. Our teams also get energy from engaging in philanthropic efforts and interacting socially, and we create ongoing opportunities to give back to our community and do fun things together—everything from book clubs to pickleball!
Kymera is committed to your whole health, and we offer several options to help you to make the best decisions for you and your family. In addition to our generous benefits plan, you’ll have access to other resources to make healthy choices, including a monthly wellness stipend and an onsite gym membership.
You want to challenge yourself, learn new skills, and thrive professionally, and we’ll support you starting on day one. Tools and training to be more effective with communication and teamwork, curated courses to support your learning journey, and a whole month dedicated to your development are all a part of life at Kymera. If you’re a manager or aspiring to lead others, we have a learning series to maximize your impact. If you enjoy learning on your own, visit our onsite library and borrow an inspiring book or take advantage of our tuition reimbursement benefit.
Explore Open Positions
Join us on our mission to design and deliver a new generation of degrader therapies with the potential to improve patients’ lives.
